Literature DB >> 17456578

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Virginia A Triant1, Hang Lee, Colleen Hadigan, Steven K Grinspoon.   

Abstract

CONTEXT: Metabolic changes and smoking are common among HIV patients and may confer increased cardiovascular risk.
OBJECTIVE: The aim of the study was to determine acute myocardial infarction (AMI) rates and cardiovascular risk factors in HIV compared with non-HIV patients in two tertiary care hospitals. DESIGN, SETTING, AND PARTICIPANTS: We conducted a health care system-based cohort study using a large data registry with 3,851 HIV and 1,044,589 non-HIV patients. AMI rates were determined among patients receiving longitudinal care between October 1, 1996, and June 30, 2004. MAIN OUTCOME MEASURES: The primary outcome was myocardial infarction, identified by International Classification of Diseases coding criteria.
RESULTS: AMI was identified in 189 HIV and 26,142 non-HIV patients. AMI rates per 1000 person-years were increased in HIV vs. non-HIV patients [11.13 (95% confidence interval [CI] 9.58-12.68) vs. 6.98 (95% CI 6.89-7.06)]. The HIV cohort had significantly higher proportions of hypertension (21.2 vs. 15.9%), diabetes (11.5 vs. 6.6%), and dyslipidemia (23.3 vs. 17.6%) than the non-HIV cohort (P < 0.0001 for each comparison). The difference in AMI rates between HIV and non-HIV patients was significant, with a relative risk (RR) of 1.75 (95% CI 1.51-2.02; P < 0.0001), adjusting for age, gender, race, hypertension, diabetes, and dyslipidemia. In gender-stratified models, the unadjusted AMI rates per 1000 person-years were higher for HIV patients among women (12.71 vs. 4.88 for HIV compared with non-HIV women), but not among men (10.48 vs. 11.44 for HIV compared with non-HIV men). The RRs (for HIV vs. non-HIV) were 2.98 (95% CI 2.33-3.75; P < 0.0001) for women and 1.40 (95% CI 1.16-1.67; P = 0.0003) for men, adjusting for age, gender, race, hypertension, diabetes, and dyslipidemia. A limitation of this database is that it contains incomplete data on smoking. Smoking could not be included in the overall regression model, and some of the increased risk may be accounted for by differences in smoking rates.
CONCLUSIONS: AMI rates and cardiovascular risk factors were increased in HIV compared with non-HIV patients, particularly among women. Cardiac risk modification strategies are important for the long-term care of HIV patients.

Entities:  

Mesh:

Year:  2007        PMID: 17456578      PMCID: PMC2763385          DOI: 10.1210/jc.2006-2190

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.

Authors:  P Maggi; G Serio; G Epifani; G Fiorentino; A Saracino; C Fico; F Perilli; A Lillo; S Ferraro; M Gargiulo; A Chirianni; G Angarano; G Regina; G Pastore
Journal:  AIDS       Date:  2000-11-10       Impact factor: 4.177

2.  Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Authors:  J H Stein; M A Klein; J L Bellehumeur; P E McBride; D A Wiebe; J D Otvos; J M Sosman
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

3.  Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.

Authors:  K A Lichtenstein; D J Ward; A C Moorman; K M Delaney; B Young; F J Palella; P H Rhodes; K C Wood; S D Holmberg
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

4.  Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

Authors:  C Hadigan; J B Meigs; C Corcoran; P Rietschel; S Piecuch; N Basgoz; B Davis; P Sax; T Stanley; P W Wilson; R B D'Agostino; S Grinspoon
Journal:  Clin Infect Dis       Date:  2000-12-15       Impact factor: 9.079

5.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

6.  Coronary heart disease in HIV-infected individuals.

Authors:  Judith S Currier; Anne Taylor; Felicity Boyd; Christopher M Dezii; Hugh Kawabata; Beth Burtcel; Jen-Fue Maa; Sally Hodder
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

7.  Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Authors:  Murielle Mary-Krause; Laurent Cotte; Anne Simon; Maria Partisani; Dominique Costagliola
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

8.  Impact of HIV infection and HAART on serum lipids in men.

Authors:  Sharon A Riddler; Ellen Smit; Stephen R Cole; Rui Li; Joan S Chmiel; Adrian Dobs; Frank Palella; Barbara Visscher; Rhobert Evans; Lawrence A Kingsley
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

9.  Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.

Authors:  Colleen Hadigan; James B Meigs; Peter W F Wilson; Ralph B D'Agostino; Benjamin Davis; Nesli Basgoz; Paul E Sax; Steven Grinspoon
Journal:  Clin Infect Dis       Date:  2003-03-20       Impact factor: 9.079

10.  Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Authors:  Daniel Klein; Leo B Hurley; Charles P Quesenberry; Stephen Sidney
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-15       Impact factor: 3.731

View more
  712 in total

Review 1.  Dyslipidemia and its Treatment in HIV Infection.

Authors:  Carl Grunfeld
Journal:  Top HIV Med       Date:  2010 Aug-Sep

2.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

Authors:  Rebeccah A McKibben; Joseph B Margolick; Steven Grinspoon; Xiuhong Li; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Richard T George; Lisa P Jacobson; Matthew Budoff; Russell P Tracy; Todd T Brown; Wendy S Post
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

3.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

4.  Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.

Authors:  John R Koethe; Aihua Bian; Ayumi K Shintani; M Sean Boger; Valerie J Mitchell; Husamettin Erdem; Todd Hulgan
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

5.  Progress in prevention: improving cardiovascular risk management among human immunodeficiency virus-positive individuals.

Authors:  Jason E Farley; Carrie Tudor; Cheryl R Dennison
Journal:  J Cardiovasc Nurs       Date:  2010 Jul-Aug       Impact factor: 2.083

6.  Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; Gabriel Somarriba; E John Orav; Armando J Mendez; Daniela Neri; Natasha Schaefer; Lourdes Forster; Ronald Goldberg; Gwendolyn B Scott; Steven E Lipshultz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

7.  New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis.

Authors:  Cleophas Chimbetete; Catrina Mugglin; Tinei Shamu; Bindu Kalesan; Barbara Bertisch; Matthias Egger; Olivia Keiser
Journal:  Trop Med Int Health       Date:  2017-06-08       Impact factor: 2.622

8.  The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro.

Authors:  Shannon G Loelius; Katie L Lannan; Neil Blumberg; Richard P Phipps; Sherry L Spinelli
Journal:  Thromb Res       Date:  2018-07-06       Impact factor: 3.944

Review 9.  Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice.

Authors:  Enrico Cerrato; Fabrizio D'Ascenzo; Giuseppe Biondi-Zoccai; Pierluigi Omedè; Claudio Moretti; Stefania Cicalini; Gurumurthy Parthasarathi; Imad Sheiban; Fiorenzo Gaita
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

10.  Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).

Authors:  Martin Tibuakuu; Di Zhao; Ankita Saxena; Todd T Brown; Lisa P Jacobson; Frank J Palella; Mallory D Witt; Susan L Koletar; Joseph B Margolick; Eliseo Guallar; Sai Krishna C Korada; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.